Kaomi ma aneʻi e hōʻike i kāu mau hae ma kēia ʻaoʻao a uku wale no ka holomua

Nuhou Uea

Kōkua ka hoʻomaha ʻana o ka ʻūmā i ka mālama ʻana i ka hemahema o ka māmā

i kakauia ma hoʻoponopono

Ua hoʻolaha ʻo CytoSorbents Corporation e komo ka Hui i ka 10th EuroELSO Congress (EuroELSO 2022) ma Lākana, UK e mālama ʻia ana mai Mei 4-6, 2022, kekahi o nā hālāwai kūkā nui ʻelua no nā mea hoʻohana ECMO (extracorporeal membrane oxygenation) ma ka honua holoʻokoʻa. Ke hōʻike nei ʻo CytoSorbents i ka hoʻolālā o ka "hoʻomaha hoʻomaha hoʻonui" me ka hoʻohana ʻana iā CytoSorb me ECMO e kōkua i ka mālama ʻana i ka maʻi ʻeha hanu acute respiratory (ARDS) a me ka pau ʻole o ka pulupulu - nā kumu nui o ka make i nā maʻi maʻi ICU. 

E hōʻike ʻia nā ʻikepili hou mai 56 mau maʻi maʻi maʻi COVID-19 me ka hāʻule ʻole ʻana o ka hanu ma ke kākoʻo ola me ECMO a mālama ʻia me CytoSorb ma lalo o ka FDA Emergency Use Authorization (EUA) mai ka US CTC Registry e hōʻike ʻia ma ka Pōʻalima, Mei 5, 2022, ma kahi hōʻike abstract i kapa ʻia: ECMO Utilization with Adjunctive Hemoadsorption Therapy in COVID-19 Patients: An Observational Analysis from the CytoSorb Therapy in COVID-19 (CTC) Registry. Ke kākoʻo nei kēia loiloi hou i ke koʻikoʻi o ka hana mua ʻana me CytoSorb a me ECMO i ka mālama ʻana i nā maʻi me ka ARDS e pili ana i ka COVID, a me kāna kuleana kūpono i ke ola kiʻekiʻe o nā mea maʻi he 52 i kahi loiloi mua o ke kākau inoa, i paʻi ʻia ma ka puke pai i nānā ʻia e nā hoa. Frontiers in Medicine, i ka makahiki i hala.

He kākoʻo platinum ʻo CytoSorbents o ka ʻAhaʻōlelo a e hoʻokipa pū ʻo ia i kahi symposium hoʻonaʻauao ma ka pūnaewele e hoʻolaha ʻia ma ka pūnaewele EuroELSO, i kapa ʻia ʻo "ECMO plus CytoSorb - Ke Hana Pono nei mākou?" ma ka Poaha, Mei 5, 2022, mai 12:45-1:45 PM CET ma ka lumi o St. James.

Pūnaewele

No ka mea kākau

hoʻoponopono

ʻO Linda Hohnholz ka Lunahooponopono no eTurboNew. Aia ʻo ia ma ka eTN HQ ma Honolulu, Hawaii.

Waiho i ka manaʻo

Kaʻana like i...